Personalized Therapeutics.
Discovered in Minutes.
Empowering research labs to find cures by synthesizing patient profiles with Evo2 genomic analysis, TinyFish clinical intelligence, and AlphaFold in-silico experimentation.
1. Comprehensive Patient Profiling
Labs request access and create detailed patient profiles. We ingest multi-modal clinical data to build a complete digital twin for targeted drug discovery.
Demographics
Baseline characteristics and vital statistics.
Clerkings
Detailed clinical history and physician notes.
Treatments
Historical interventions and patient responses.
Radiology
Imaging reports and spatial biomarker data.
Genomics
WGS and RNA-seq data, crucial for cancer profiling.
2. Evo2 Genomic Analysis
Identifying mutations and target genes for comprehensive diagnostic reporting.
Comprehensive Reporting
The Bio Evo2 model maps structural differences to highlight areas of critical clinical importance.
3. TinyFish Clinical Intelligence
Autonomous web agents extracting top techniques, methodologies, and viable drugs from global clinical trials.
| Methodology / Drug | Source | Target Mechanism | Efficacy Score |
|---|---|---|---|
| Pembrolizumab (Keytruda) | Clinical Trial | PD-L1 Checkpoint Inhibition | 98% |
| CAR-T Cell Therapy | Medical Journal | Cellular Reprogramming | 82% |
| Ruxolitinib | Pharma Portal | JAK-STAT Pathway Modulation | 75% |
AlphaFold Docking & ADMET Analysis
Generate patient-specific protein structures using AlphaFold. Conduct high-throughput molecular docking and comprehensive ADMET analysis to validate therapeutic viability before clinical application.